Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New model could predict lymphoma progression within two years

NCT ID NCT03436602

First seen Nov 18, 2025 · Last updated May 21, 2026 · Updated 22 times

Summary

This study aims to create a more accurate tool to predict whether follicular lymphoma patients will remain free of cancer progression two years after their first treatment. Researchers are combining clinical information with molecular data from 370 patients to build and test this personalized risk model. The goal is to better identify which patients are likely to do well and which may need closer monitoring or different treatment approaches.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Arcispedale Santa Maria Nuova, AUSL IRCSS, Hematology Department

    Reggio Emilia, RE, 42123, Italy

  • Azienda Ospedaliera Universitaria Maggiore della Carità

    Novara, 28100, Italy

  • Institute of Oncology Research

    Bellinzona, Canton Ticino, 6500, Switzerland

  • Institute of Pathology

    Locarno, Canton Ticino, Switzerland

Conditions

Explore the condition pages connected to this study.